Literature DB >> 6940647

Preleukemic states in children with acute lymphoblastic leukemia.

R H Sills, J A Stockman.   

Abstract

Two cases are reported of childhood acute lymphoblastic leukemia presenting with preleukemic states and 13 other cases in the literature are reviewed. Hypoplastic anemias, which transiently resolved spontaneously or with steroid therapy, were seen most commonly. Acquired hypoplastic anemias, even when associated with spontaneous resolution, may at times represent a preleukemic state.

Entities:  

Mesh：

Year:  1981        PMID： 6940647     DOI： 10.1002/1097-0142(19810701)48:1<110::aid-cncr2820480121>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


  5 in total

1.  Neutropenia preceding acute lymphoblastic leukaemia.

Authors:  P C Shepherd; G M Corbett; N C Allan
Journal:  J Clin Pathol       Date:  1988-06       Impact factor: 3.411

2.  Distinction between aleukaemic prodrome of childhood acute lymphoblastic leukaemia and aplastic anaemia.

Authors:  M M Reid; G P Summerfield
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

3.  Acute lymphoblastic leukaemia presenting as aplastic anaemia.

Authors:  P N Cheng; C S Ng; R L Brearley
Journal:  J R Soc Med       Date:  1987-02       Impact factor: 18.000

4.  Pancytopenic prodrome (pre-ALL) of acute lymphoblastic leukemia in adults: possible pathogenesis.

Authors:  S K Sohn; J S Suh; J Lee; K B Lee
Journal:  Korean J Intern Med       Date:  1998-02       Impact factor: 2.884

5.  The distinguishable DNA whole genome methylation profile of 2 cases of pediatric precursor B acute lymphoblastic leukaemia (BCP ALL) with prodromal, preleukemic phase: A case report.

Authors:  Radosław Chaber; Artur Gurgul; Grażyna Wróbel; Anna Tomoń; Sylwia Paszek; Natalia Potocka; Olga Haus; Monika Lejman; Kornelia Łach; Tomasz Szmatoła; Igor Jasielczuk; Blanka Rybka; Renata Ryczan-Krawczyk; Sylwia Stąpor; Krzysztof Ciebiera; Christopher J Arthur; Izabela Zawlik
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.